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ABSTRACT
Atrial fibrillation is the most common heart arrhythmia of clinical significance. Internal
cardioversion can be used to restore normal sinus rhythm; however, the amount of delivered
energy elicits intolerable pain. Lowering delivered energy could make implantable cardioverters
a promising treatment option. This study simulated cardioversion shocks in a model of the
human heart using finite element analysis to determine effects of different electrode placements
on defibrillation threshold (DFT) and esophageal electric field (EEF) near the left atrium. Ten
right atrial to coronary sinus electrode placements were tested. Small shifts in electrode
placements changed DFT by up to 42%, indicating electrode position is an important factor in
lowering DFT. A relationship was not discovered between EEF and DFT. If a relationship can
be discovered between an alternate EEF or other measure and DFT, electrode placements could
be optimized on a patient-specific basis to lower delivered energy to painless or tolerable levels.
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Introduction/Background
Atrial fibrillation (AF) is the most common heart arrhythmia throughout the U.S. and
European countries and is the most clinically significant arrhythmia, affecting over 33 million
people worldwide.1 As the population grows older, AF is becoming more prevalent in older
patients. Patients in the age range of 65-85 years old make up approximately 70% of AF cases.2
Several studies have reported AF incidence and prevalence, and the majority predict that the
prevalence of AF will increase rather rapidly in the coming years.3-5 In the U.S., some studies
predict that the number of people having AF in the year 2050 will be 5.6 million6, while another
study predicts that number to be as high as 12 million.5 In Europe, that number is predicted to be
even higher at 17 million in the year 2060.5 With the increasing number of cases of AF, the U.S.
national healthcare costs to treat this arrythmia range from $6 billion up to $26 billion and
include inpatient, outpatient and pharmacy costs.7 This growing concern calls for more effective
treatments to prolong the quality of life for people affected by AF.
AF is a supraventricular tachycardia (SVT) in which there are rapid, irregular
contractions of the muscle fibers in the atria. These irregular contractions are often due to
reentrant electrical wavefronts and are associated with a variety of health risks for those with AF,
including stroke, valvular heart disease, hypertension and other potential life-threatening
conditions if not properly treated.8
AF has been treated over the years by a range of methods in order to return the heart to
sinus rhythm, including electrical cardioversion, antiarrhythmic drug therapies and ablation. The
efficacy of each method is dependent upon each patient, namely the severity of AF, other health
(especially cardiac) related problems and the length of time experiencing AF. Some of the
antiarrhythmic drugs prescribed for treatment of AF include dofetilide, flecainide, propafenone,
1

sotalol and quinidine. These drugs aim to alleviate reentrant wavefronts, but do not have
constant efficacy.9 When these drugs do not effectively treat a patient, catheter ablation can be
performed to prevent the recurrence of AF by first sedating the patient, inserting one or more
intravenous catheters with electrodes, recording and pacing in various intracardiac locations,
followed by directed radiofrequency (RF) energy to burn and destroy the tissue causing the
reentrant electrical wavefronts.10 However, this is an invasive surgical procedure and even when
successful, ablation is often needed more than once. External cardioversion is a common
technique performed clinically, typically using self-adhesive electrodes applied to the anterior
and/or posterior chest. A shock or series of shocks is delivered to the patient’s chest to restore
sinus rhythm. Similarly, internal cardioversion is a viable means to successfully restore sinus
rhythm, with catheter electrodes inserted intravenously inside the patient’s heart. Animal and
human studies have verified the efficacy of internal cardioversion for AF11-12 and implantable
cardioversion devices could be an effective treatment alternative. However, the major limiting
factor for internal cardioversion of AF via an implantable device is that the amount of energy
currently required to restore sinus rhythm elicits pain and discomfort to the patient. Several
studies have shown that low energy shocks greater than 2 J can cause intolerable pain to
patients.13-15 One study explored different mechanisms of pain as a result of internal
defibrillation shocks that ranged from 50-500 V.16 The human pain threshold of approximately 12 J makes internal defibrillation a limited, sometimes impossible solution for treatment of AF.17
There have been numerous animal, human and simulation studies to develop and test
techniques to lower the amount of delivered energy to the patient with an implantable
defibrillator in order to reduce delivered energy to near or below the human pain threshold and
still successfully terminate AF. Different strategies to determine if the delivered energy can be
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lowered to the desirable range have been studied. Waveform optimization has been explored to
determine which type of waveform, such as monophasic or biphasic waveform, is most effective
for internal cardioversion. One study tested a passive implantable atrial defibrillator (having no
battery or discharging capacitor and driven solely by RF energy) that delivered a low-tilt
monophasic waveform, compared to three different biphasic waveforms, to determine if
waveform selection can improve the efficacy of defibrillation.18 Another strategy to lower the
delivered energy is to predict an optimal electrode placement. Various human and animal
studies have tested several different electrode configurations, including a right atrium to
coronary sinus configuration, defibrillator “can” to right ventricle and right atrium configuration
and right atrium to left pulmonary artery configuration, and have compared the rates of atrial
defibrillation success for each configuration. The right atrial-coronary sinus configuration has
been found to successfully defibrillate the heart with the least amount of energy, and as a result
this is a common clinical electrode configuration. One study showed that this configuration
greatly lowered the DFT compared to a different configuration, with 91% of patients having
restored sinus rhythm.19 A separate simulation study tested three different electrode
configurations in a canine heart to determine various factors after electric field exposure,
including amount of atrial myocardium damaged, inter-electrode impedance, electric field
strength and the magnitude of the voltage gradient. The electrode configurations tested indicated
a lower impedance, stronger electric field strength in the atrial myocardium and minimal
myocardial damage.20 Another potential factor in determining an optimal electrode placement is
the idea that esophageal electric fields (EEFs) can be predictive of atrial cardioversion success.
Fitch et al. performed a finite element analysis in external cardioversion, testing over 600
electrode configurations, determining that small shifts in the electrode placement from an initial
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clinically relevant position can lower the defibrillation threshold (DFT), defined as the applied
voltage required to produce an electric field of 5 V/cm throughout the atrial myocardium.21 In a
separate study, Fitch et al. investigated the relationship between EEFs and DFTs by inducing and
cardioverting AF in pigs. The results indicated a strong negative relationship between the EEFs
and DFTs, indicating that EEFs could be a potential predictor for optimal electrode placements.22
If an optimal electrode placement can be predicted using EEFs measured prior to cardioversion,
the energy delivered to the patient could be lowered to tolerable pain levels.
Objectives
The purpose of this study was to determine the effects of various electrode placement(s)
on the DFTs required for internal cardioversion of atrial fibrillation and explore a potentially
predictive measure for lowering DFTs. This overall goal was achieved through the following
objectives: (1) simulate cardioversion shocks in an anatomically realistic model of the heart
using finite element analysis, (2) determine the effect of various electrode placements on
delivered energy, and (3) determine if a positive or negative relationship exists between electric
field in the esophagus and DFTs. First, an anatomically realistic model was developed by
extracting 3D surfaces from stacked computed tomography (CT) images of the heart. The
anatomy consisted of the heart with both atrial and ventricular myocardium and blood pools, the
descending aorta, the lungs and the esophagus, surrounded by a bounding box to ensure proper
boundary conditions. Electrode geometry was created and inserted into different locations in the
right atrium and coronary sinus region. Finite element analysis was performed in COMSOL to
determine the electric fields produced in the atrial myocardium by ten different electrode
configurations. The atrial electric field data were exported and used to determine the DFT.
Additionally, the average electric field strength produced in a selected region of the esophagus
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was analyzed to determine whether it correlated with the DFT of the atrial tissue and thus aid in
determining optimal electrode placement.
Methods
Anatomical Model
The software used to develop the anatomical geometry was Materialise MIMICS
Research version 21.0 and Materialise 3-Matic Research version 13.0. The CT scan used was
the heart_se.mcs file that is provided with the student edition of the MIMICS software. The CT
images were taken from a 55-year old female in October 2007 using a LightSpeed VCT scanner
from GE Medical Systems. The scan contains 193 slices with a slice thickness of 0.625 mm.
Information from Materialise’s HeartPrint® Imaging Guidelines23 gives a general rule for
cardiac scan protocol; that the images are obtained using a “standard ECG-triggered diastolic
protocol with good contrast,” and more notably that ideally the heartbeat is below 65 bpm and
the patient is holding her breath. Also, to better understand the anatomy of the patient, an
anatomical atlas was referenced to specify the locations of various parts of the heart and other
organs.24
To begin developing the 3D models of each individual organ, the heart_se.mcs file was
opened in MIMICS, and segmentation by thresholding of the CT image was performed to
highlight the specific anatomy that needed to be modeled. The primary focus of the modeling
process was the heart, and the accuracy of the four endocardial surfaces of the heart as well as
the myocardial tissue were the most important aspect of the model. To easily extract the electric
field data in the atrial myocardium, the myocardium was split between its atrial and ventricular
components.

5

After performing an initial thresholding operation, implementation of the region growing
tool aided in distinguishing between the different organs and creating separate masks for each
individual organ. Next, a 3D part was created using the “high quality” parameter setting for each
organ using an adapted marching cubes algorithm.25 If the 3D model did not include all the
surface needed, more segmentation was performed including multiple slice editing. Once the
desired accuracy and level of detail for each anatomical component was achieved, each model
was exported to 3-Matic. Working in 3-Matic, each model was refined further by using the wrap
and smooth operations. Wrapping the models serves to close in holes, smooth out each 3D part,
and remove internal shells, creating a sealed, watertight model. The smooth operation smooths
the model and decreases the sharp edges throughout. Similarly, local smoothing allows for
smoothing in certain areas of the geometry which need refining as opposed to the entire
geometry. The myocardium was hollowed by performing a Boolean subtraction of the
myocardium from the endocardial surfaces. To ensure the nodes of the tetrahedra in the
myocardium aligned properly, a non-manifold assembly joined the atrial and ventricular
myocardium, then subsequently the parts were separated, and the interface of the assembly was
joined to both myocardial parts. Performing an adaptive remesh on the surface on each part with
the skewness shape measure ensured a high-quality mesh. The final step before volume mesh
creation was to utilize the fix wizard to check for any holes, overlapping and intersecting
triangles and inverted normals. These steps were repeated until all errors were fixed and the
desired mesh quality was achieved.
The electrode geometries were created in 3-Matic using the analytical primitives menu.
Because studies have shown that the right atrial-coronary sinus electrode configuration can
successfully defibrillate the heart with the lowest amount of delivered energy, this configuration
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was chosen for investigation in this study. Two electrodes were created near the coronary sinus
region and five electrodes were placed in the right atrium. Volume meshes were then created for
each part of the model, including all organs, the bounding box and the electrodes. Before
exporting the volume meshes to COMSOL, the final step was to view the contours of the volume
meshes in MIMICS to verify that the mesh nodes matched up appropriately. Table 1 lists the
number of tetrahedra in several meshes of the model as well the total volume of those meshes.
Table 1: Number of Tetrahedra and Total Volume of the Heart Regions
Anatomy
Number of Tetrahedra
Total Volume (mm3)
Atrial Myocardium
243,060
138,500
Ventricular Myocardium
373,909
232,100
Atrial Blood Cavity
168,663
114,500
Ventricular Blood Cavity
242,677
167,100

The figures below indicate several stages of the modeling process, including the original
threshold of the cardiac anatomy (Figure 1), anterior and posterior views of the 3D heart model
(Figure 2), an isometric view of the entire model with all anatomy included (Figure 3), an axial
view of the contours of the volume meshes of the atrial and ventricular myocardium (Figure 4)
and a panel of all the electrode placements (Figure 5).
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Figure 1: Original threshold of cardiac anatomy in the axial view, where A indicates anterior, P
indicates posterior, R indicates right, L indicates left, 60.00 indicates slice number, and -160.00
indicates table position, which is the location of the examination table as the CT scanning
proceeds.

Figure 2: Anterior/posterior view of the epicardial surfaces of the right and left atrium and right
and left ventricles.
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Left Lung

Esophagus
Atrial Myocardium

Ventricular Myocardium

Descending Aorta

Right Lung

Figure 3: Isometric view of the model. The myocardium is shown in pink (ventricular) and
grey (atrial), lungs in green, esophagus in yellow and descending aorta in purple.

Figure 4: Axial view of contours of the volume mesh of the atrial and ventricular
myocardium. Atrial myocardium in pink, ventricular myocardium in white. Inset shows a
portion of interface between atria and ventricles.
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Figure 5: Lateral views of atrial electrode placements: a. atrial myocardium
with coronary sinus displayed as an opaque surface, b. atrial myocardium with
CS1 electrode, c. atrial myocardium with CS2 electrode, and d. right atrium
with right atrial electrodes notated from left to right as: RAL1, RAL4, RAL2,
RAL3, and RAS5. CS = Coronary Sinus, RAL = Right Atrial Lateral, RAS =
Right Atrial Septal. Epicardial and endocardial surfaces are transparent.
For the purposes of this study, two electrodes were tested in each simulation, with the coronary
sinus electrode (CS1) being stationary, and the right atrial electrode shifting to five different
locations along the lateral and septal wall. The coronary sinus electrode was shifted to a new
location (CS2), and the same five right atrial electrode locations were tested, for a total of ten
electrode configurations. The notation of the electrode configurations is CS1_RAL1,
CS1_RAL2, CS1_RAL3, CS1_RAL4, CS1_RAS5, CS2_RAL1, CS2_RAL2, CS2_RAL3,
CS2_RAL4 and CS2_RAS5.
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Finite Element Simulations
The simulations were carried out in COMSOL Multiphysics 5.4 through the Research
Desktop of the Citrix Workspace virtual computing environment at University of Memphis.
Simulated cardioversion shocks were tested in the anatomically realistic, volume conductor
model of the heart using finite element meshes and finite element analysis. To begin work on the
simulations, the meshes were imported into COMSOL. After importing each mesh, the
boundaries of each mesh were explicitly defined to set up identity boundary pairs between the
boundaries of two separate meshes that had touching boundaries. These identity boundary pairs
ensure continuity on the interior boundaries of the touching meshes to allow current to flow
properly through the entire model.
Once all the boundaries of the meshes were appropriately defined, the electric currents
physics module was implemented to define electrical conductivity values of the various tissues
and blood, continuity on the interior boundaries and the electric potential at the electrodes. The
governing formulation is Laplace’s equation:
⃗𝛁
⃗ . 𝝈𝛁𝝓 = 𝟎

(1)

where, 𝝈 represents the conductivity as a tensor and 𝝓 is the electric potential. The Neumann or
natural boundary conditions are applied on the body surface, in which current can neither enter
nor leave the volume except at the locations of the defibrillation electrodes. A stationary, nontime varying study with isotropic conductivities (scalar σ) was performed to determine the
electric field distribution in the atria and esophagus. The bounding box as well as the esophagus
were assigned the conductivity of connective tissues, and the endocardial surfaces were assigned
the conductivity of blood. Table 2 lists these conductivity values, as reported by Rush and
Geddes.26-27
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Table 2: Electrical Conductivity Values of Each Tissue Region
Tissue Region
Conductivity (S/m)
Connective Tissue
0.222
Esophagus
Ventricular Myocardium
0.25
Atrial Myocardium
Descending Aorta
Ventricular Blood Pool
0.667
Atrial Blood Pool
Descending Aorta Blood Pool
Lungs
0.078
The electric currents module in COMSOL was used for the finite element formulation.
After assigning all conductivity values, continuity was defined on interior boundaries to ensure
current flowed through all the tissue and electrical potential difference of 200 V was applied to
the electrodes, then the study was computed. After completing a simulation, plots of the electric
field in the atrial myocardium and esophagus were observed qualitatively, and the electric field
values of the atrial myocardium and esophagus were extracted to a text file. The text files
included the x, y and z coordinates of the center of each tetrahedron, the volume of each
tetrahedron and the electric field value of each tetrahedron at those coordinates. The electric
field data points were extracted from the centroid of each tetrahedron using the Gauss integration
point. For the esophageal data, only the values in tetrahedra most adjacent to the left atrium
between z-coordinates of -170 to -190 mm were exported, as shown in Figure 6 below. Each
text file of data was then imported in Excel for data analysis.
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Figure 6: Lateral view of atrial myocardium and esophagus, with dashed lines indicating the
approximate range of electric field data extracted from the esophagus.
Data Analysis
To determine the DFT voltage, the applied voltage to the electrodes was scaled to
produce a minimum electric field of 5 V/cm in 95% of the tetrahedral volume elements
representing the atrial tissue. The electric field values were sorted in ascending order, and the
volumes of the corresponding tetrahedra were summed until 95% of the atrial volume was
reached. To verify the simulations, the simulations were computed again, applying the DFT
voltages rounded to the nearest whole number on the electrodes. The data was extracted again,
and the volumes summed up to 95% of the atrial volume. The electric field at 95% of the volume
yielded 5 V/cm, thus verifying the simulation. The average electric field in the portion of the
esophagus adjacent to the atria was calculated.
A brief mesh convergence study was performed, testing the model with a coarser and
finer mesh of the heart for the CS2_RAL1 electrode configuration to determine any changes in
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the DFT. Table 3 below lists the number of tetrahedra and total volumes of the heart in each
mesh. The fine mesh was implemented in all ten electrode configurations.
Table 3:Number of Tetrahedra in Heart for Mesh Convergence
Anatomical Part
Coarse Mesh
Fine Mesh
Tetrahedra
Tetrahedra
Ventricular
255,373
373,909
Myocardium
Atrial Myocardium
138,524
243,060
Ventricular Blood
188,107
242,677
Pool
Atrial Blood Pool
145,582
168,663
Total
728,061
1,028,309

Finer Mesh
Tetrahedra
975,121
696,874
506,139
345,745
2,523,879

After calculating the DFT voltages and average EEFs, the DFTs were expressed as
delivered energy using the following equation:
𝟏

𝑼 = 𝟐 𝑪𝑽𝟐

(2)

Where U is the energy stored in the pulse generator of an implantable device, C is the
capacitance of the pulse generator, assumed to be 140 µF, and V is the DFT in voltage. The
average EEFs were squared, because the DFT energy is related to voltage squared. The data
were normalized using min-max normalization to scale the data between zero and one, and a
linear regression analysis was performed comparing the normalized DFT energies with the
normalized average squared EEF voltages.
Results
Results from the finite element simulations are presented below, including plots of the
electric field in the atrial myocardium and esophagus, DFT and EEF data, the results of the linear
regression analysis and the mesh convergence data.
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Mesh Convergence Study
The DFTs and total volumes of the atrial myocardium in the mesh convergence study are
listed in Table 4. There was a 0.34% increase in the DFT comparing the coarse heart mesh to the
fine heart mesh. Likewise, there was a 0.25% increase between the fine heart mesh and the finer
heart mesh. As a result of this low percent increase the fine mesh was chosen for the ten
simulations. Qualitative comparison of the electric field distribution in the atrial myocardium for
each mesh indicate that the spatial distribution of electric field is not different between meshes
(Figure 7).
Table 4: DFTs and Volumes of Atrial Myocardium in Mesh Convergence Study
Mesh Type
DFT (V)
Volume (mm3)
Coarse
28.381
131,500
Fine
28.477
138,500
Finer
28.548
148,000

Figure 7: Anterolateral views of electric field in atrial myocardium of CS2_RAL1: a. coarse
mesh; b. fine mesh; c. finer mesh, and posterolateral views of electric field in atrial myocardium
of CS2_RAL1: d. coarse mesh; e. fine mesh; f. finer mesh of the mesh convergence study.
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Electric Field Distribution
The following figures (Figures 8-12) show the electric field distribution in the atrial
myocardium and the esophagus for four different electrode configurations with 200 V potential
difference. The electric field distribution shifted throughout the right atrium in numerous
electrode configurations based on the position of the right atrial electrode and produced varying
DFTs and EEF values. The electric field remained fairly concentrated near the coronary sinus as
the electrodes were shifted only slightly, whereas most of the variation was produced from the
right atrial electrode due to the shifting of the electrode throughout the right atria. The electric
field is heavily concentrated at the electrodes and disperses from them.

Figure 8: Electric field distribution in the atrial myocardium for CS1_RAL4 configuration in the
atrial myocardium. A 200 V potential difference was applied between the electrodes. Electric
field values are in V/cm.
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Figure 9: Electric field distribution in the atrial myocardium for CS2_RAL4 configuration in the
atrial myocardium. A 200 V potential difference was applied between the electrodes. Electric
field values are in V/cm.

Figure 10: Electric field distribution in the atrial myocardium for CS1_RAS5 configuration in
the atrial myocardium. A 200 V potential difference was applied between the electrodes.
Electric field values are in V/cm.
17

Figure 11: Electric field distribution in the atrial myocardium for CS2_RAS5 configuration in
the atrial myocardium. A 200 V potential difference was applied between the electrodes.
Electric field values are in V/cm.
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Figure 12:Lateral views of electric field distribution in the atrial myocardium and esophagus for
four different electrode configurations: a. CS1_RAL3; b. CS2_RAL3; c. CS1_RAL4; d.
CS2_RAL4; A 200 V potential difference was applied between the electrodes. Electric field
values are in V/cm.
DFTs, Average EEFs, and Regression Analysis
The DFTs and average EEFs had similar values for both CS placements and shifting the
right atrial electrode throughout the right atrium. Specifically, the CS electrode placement did
not affect the average EEF or DFT for a given RA placement. For all ten configurations, there
was a 42% increase in the DFT from the lowest to the highest DFT. Likewise, for the average
EEF data, there was a 126% increase between the lowest and highest average EEFs. However,
these EEF values did not correspond with the lowest and highest DFTs.
The non-normalized DFT data are given in Table 5 below. The average EEFs for each
electrode configuration are shown below in Figure 13. A regression analysis compared the
normalized DFTs with the normalized EEFs by calculating the coefficient of determination (R2),
shown in Figure 14 below. The data showed no relationship between the DFTs and average
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EEFs, however there were several simulations with equal and low DFTs. RAL1 and RAS5
produced the lowest DFTs for both CS placements. It also appeared that a larger percent
increase in the DFT occurred between the RAL electrodes in closer proximity to one another.
Table 5: DFT Voltages for Each Electrode Configuration
Electrode Configuration
DFT (V)
CS1_RAL1
28
CS1_RAL2
34
CS1_RAL3
30
CS1_RAL4
33
CS1_RAS5
26
CS2_RAL1
28
CS2_RAL2
37
CS2_RAL3
31
CS2_RAL4
35
CS2_RAS5
28

DFT (J)
0.055
0.08
0.063
0.076
0.047
0.055
0.096
0.067
0.086
0.055

9
8
7

Average EEF (V)

6
5
4
3
2
1
0
CS1_RAL1 CS2_RAL1 CS1_RAL2 CS2_RAL2 CS1_RAL3 CS2_RAL3 CS1_RAL4 CS2_RAL4 CS1_RAS5 CS2_RAS5

Electrode Configurations

Figure 13: The average EEF with standard deviation bars for each electrode configuration.
The average EEF was not influenced by the CS placement for a given RA placement.
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Normalized DFT

Figure 14: The comparison between the normalized DFTs and normalized average squared
EEFs for each electrode configuration. The DFT energies and average squared EEF voltages
were normalized. The coefficient of determination shows there is no relationship between the
DFTs and average EEFs for these given electrode configurations.
Discussion
Previous studies on atrial DFTs and electrode placement have focused on external
defibrillation or internal defibrillation studies in various animal models. For this work, internal
defibrillation was investigated by developing a finite element analysis study conducted on an
anatomically realistic, volume conductor model of the heart and surrounding organs of a human
female. This study aided in determining variations in the DFT, average EEF adjacent to the left
atrium and electric field distribution of the atrial myocardium by testing ten different clinically
relevant internal electrode configurations.
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Effect of Electrode Placement on DFTs and Average EEFs
This study simulated cardioversion shocks in an anatomically realistic model of the heart
using finite element analysis and investigated the effect of various electrode placements on DFTs
and average EEFs. However, a positive or negative relationship between the average EEFs and
DFTs could not be determined. Despite this, several electrode configurations had low DFTs,
with a 42% increase from the lowest to highest DFT. This data indicates that internal electrode
placement is an important factor in lowering the delivered energy to the patient using an
implantable defibrillator for treatment of AF. However, a relationship was not observed between
the DFTs and the average EEFs, and the likelihood of predicting an optimal electrode placement
based on the average EEF is still unknown. Perhaps the low sample size of ten electrode
configurations was not sufficient. Testing more configurations could prove challenging,
however, due to the limited space available in placing the coronary sinus electrode. Small shifts
could be implemented along the right atrial lateral and septal walls to increase the number of
electrode configurations. There is more room to spatially reconfigure the right atrial electrode,
yet some reconfigurations would not be clinically viable. The average EEF may not be a
predictor of the internal DFT, however various features of the average EEF could be utilized in a
clinical setting. Previous studies have found a relationship between the average EEF and DFT
for external cardioversion, suggesting that, in clinical practice, a physician could measure the
EEF, shift the electrodes in small increments while continually measuring the EEF, and place the
electrodes where the strongest EEF occurs, which would result in the lowest DFT.21-22 If more
internal configurations are tested and a similar relationship is discovered between the average
EEF and DFT, perhaps a physician could perform a similar procedure. Additionally, another
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intracardiac measure of electric field, such as in or near the interatrial septum or aortic chamber,
could show a relationship between that measure and the DFT.
Model Limitations
The model developed for this study contained sufficient levels of resolution in the
volume mesh to capture much of the cardiac detail needed to develop an anatomically realistic
model for the purposes of this study. However, some of the vasculature was left out of the
model, as it was challenging to segment, and including every detail and part of the geometry
would lead to more tetrahedral elements further increasing the simulation times. Another
limitation of this study was that the shock waveform was not specified. Even though Equation 2
is an adequate approximation for energy for a truncated exponential decay waveform in
defibrillation devices, it could be useful to investigate the effects of different waveforms on the
DFT. However, a different type of study would need to be conducted in COMSOL or a time
varying feature would need to be implemented in the model for this study. Combining waveform
optimization with this study could influence the DFT and average EEF. Also, a third limitation is
that the model in this study was passive, meaning any effects of shock timing relative to
activation distribution during AF was not modeled prior to delivering the shock. Nonetheless,
the model is sufficient to study simulated cardioversion shocks and the effect of various
electrode placements on the average EEF and DFT. Lastly, the limited number of electrode
configurations could not determine a relationship between the DFTs and average EEFs.
Future Work
The goal of this study was to analyze the atrial DFTs and average EEFs adjacent to the
left atrium in a volume conductor heart model with some surrounding organs by shifting the
coronary sinus and right atrial electrodes. Testing more electrode configurations could give
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insight into whether a relationship can be discovered between the atrial DFTs and the average
EEFs. Also, changing the range of average EEF data that was analyzed could yield different
results. Extracting EEFs from a more concentrated or expanded region of the esophagus could
demonstrate a relationship between the DFT and EEF. It could possibly be useful to investigate
any relationships between the EEF and DFT as a function of the spatial separation between and
relative orientation of the coronary sinus electrode and the right atrial electrodes, as well as the
impedance between the electrodes. It could also be beneficial to test different heart geometries
from different patients and compare the DFTs and average EEFs between patients. Many times,
cardiac treatments are patient-specific, and many factors can influence the type of treatment
available and possible for a patient.
Conclusions
With the growing concerns of an increase in the prevalence of AF, investigating novel
strategies to more effectively treat this arrhythmia with internal cardioversion and allow patients
to live more normal, higher-quality lives is crucial to make breakthroughs in this field. Although
a relationship could not be discovered between the average EEF and DFT, this study effectively
simulated internal cardioversion shocks and has shown the effects of various electrode
placements on the DFTs, resulting in low DFTs. Small shifts in the electrode placement can
change the DFT by up to 42%, a significant change in the delivered energy, which could make
the difference in a painful vs. nonpainful defibrillation threshold.
Regarding the relationship between the average EEF and DFT, future research could be
devoted to testing more electrode configurations and a different region of the esophagus to
determine whether a relationship exists for internal cardioversion. Also, a different intracardiac
measure could be investigated as a predictor of the DFT. If a relationship can be discovered
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between the EEF or another measure and the DFT, this relationship could aid a clinician in
predicting patient-specific electrode placements in order to lower delivered energy to painless or
tolerable levels.
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